Conditions: Erythropoietic Protoporphyria
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 16
Healthy volunteers: no

Brief summary:
The main objectives of the study were to evaluate the safety and tolerability of afamelanotide by measuring treatment emergent adverse events (AEs) and to determine whether afamelanotide can improve the quality of life of EPP patients.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Afamelanotide
Intervention descriptions: intervention 1: None

Protocol document: